On Tuesday, Progyny Inc (NASDAQ: PGNY) opened lower -2.00% from the last session, before settling in for the closing price of $33.06. Price fluctuations for PGNY have ranged from $29.44 to $44.95 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 61.75% over the last five years. Company’s average yearly earnings per share was noted 12.05% at the time writing. With a float of $82.69 million, this company’s outstanding shares have now reached $95.73 million.
The firm has a total of 566 workers. Let’s measure their productivity.
Progyny Inc (PGNY) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of Progyny Inc is 14.31%, while institutional ownership is 87.19%. The most recent insider transaction that took place on Nov 23 ’24, was worth 11,258. In this transaction Director of this company sold 200 shares at a rate of $56.29, taking the stock ownership to the 580,656 shares. Before that another transaction happened on Apr 01 ’24, when Company’s CHIEF FINANCIAL OFFICER sold 11,165 for $37.62, making the entire transaction worth $419,979. This insider now owns 50,119 shares in total.
Progyny Inc (PGNY) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 12.05% per share during the next fiscal year.
Progyny Inc (NASDAQ: PGNY) Trading Performance Indicators
Check out the current performance indicators for Progyny Inc (PGNY). In the past quarter, the stock posted a quick ratio of 3.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.87. Likewise, its price to free cash flow for the trailing twelve months is 16.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.62, a number that is poised to hit 0.13 in the next quarter and is forecasted to reach 0.99 in one year’s time.
Technical Analysis of Progyny Inc (PGNY)
Analysing the last 5-days average volume posted by the [Progyny Inc, PGNY], we can find that recorded value of 0.87 million was better than the volume posted last year of 0.79 million. As of the previous 9 days, the stock’s Stochastic %D was 23.87%. Additionally, its Average True Range was 1.06.
During the past 100 days, Progyny Inc’s (PGNY) raw stochastic average was set at 5.84%, which indicates a significant decrease from 12.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 25.09% in the past 14 days, which was lower than the 41.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $36.41, while its 200-day Moving Average is $36.17. Now, the first resistance to watch is $33.02. This is followed by the second major resistance level at $33.63. The third major resistance level sits at $33.97. If the price goes on to break the first support level at $32.06, it is likely to go to the next support level at $31.72. Now, if the price goes above the second support level, the third support stands at $31.11.
Progyny Inc (NASDAQ: PGNY) Key Stats
There are currently 96,110K shares outstanding in the company with a market cap of 3.13 billion. Presently, the company’s annual sales total 1,089 M according to its annual income of 62,040 K. Last quarter, the company’s sales amounted to 269,940 K and its income totaled 13,470 K.
